EP300 and colonic neoplasm: p300 interacts with XRCC5 by its HAT acetylating XRCC5 in colon cancers and cooperates with XRCC5 to regulate COX-2 expression through acetylating XRCC5 to promote colon cancer growth in vitro and in vivo [43].